CD44 and neoplasm: circCABIN1 KD substantially suppressed tumorigenicity upon in vivo serial passaging of sorted CD44+CD133+ cells, suggesting that circCABIN1 KD impaired the tumor formation ability of GSCs (Fig. 4K).